Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy

  • O. Stüve
  • , P. D. Cravens
  • , E. M. Frohman
  • , J. T. Phillips
  • , G. M. Remington
  • , G. Von Geldern
  • , S. Cepok
  • , M. P. Singh
  • , J. W. Cohen Tervaert
  • , M. De Baets
  • , D. MacManus
  • , D. H. Miller
  • , E. W. Radü
  • , E. M. Cameron
  • , N. L. Monson
  • , S. Zhang
  • , R. Kim
  • , B. Hemmer
  • , M. K. Racke

Research output: Contribution to journal › Article › peer-review

116 Scopus citations

Fingerprint

Dive into the research topics of 'Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Neuroscience